North T W, O'Connor L, Abushanab E, Panzica R P
Biochem Pharmacol. 1983 Dec 1;32(23):3541-6. doi: 10.1016/0006-2952(83)90300-3.
The antiherpes activities of erythro- and threo-9-(2-hydroxy-3-nonyl)adenines (EHNA and THNA) have been determined. All isomers inhibited the replication of herpes simplex virus (HSV) and inhibited DNA synthesis in HSV-infected cells. The two enantiomers of EHNA, (+)-EHNA and (-)-EHNA, displayed equal antiviral activities. This is in contrast to their activities as inhibitors of adenosine deaminase (ADA); (+)-EHNA is a 250-fold more potent inhibitor of ADA than (-)-EHNA [Bessodes et al. Biochem. Pharmac. 31, 879 (1982)]. The antiherpes activity of (+)-THNA was only slightly less than that of the EHNA isomers, whereas (-)-THNA was somewhat less active. The abilities of the four isomeres of EHNA and THNA to inhibit DNA synthesis in HSV-infected cells correlated with their abilities to inhibit virus multiplication. EHNA failed to inhibit HSV DNA polymerase activity in extracts from infected cells. Moreover, addition of EHNA to infected cells at 6 hr post-infection resulted in no inhibition of DNA synthesis. These results are inconsistent with a direct inhibition of macromolecular DNA synthesis by EHNA. Treatment of HSV-infected cells with EHNA produced a 2- to 4-fold decrease in levels of the four DNA precursors, deoxyribonucleoside 5'-triphosphates (dNTPs). This treatment had much less effect on dNTP levels in uninfected cells.
已测定了赤藓型和苏阿糖型9-(2-羟基-3-壬基)腺嘌呤(EHNA和THNA)的抗疱疹活性。所有异构体均抑制单纯疱疹病毒(HSV)的复制,并抑制HSV感染细胞中的DNA合成。EHNA的两种对映体,(+)-EHNA和(-)-EHNA,表现出相同的抗病毒活性。这与其作为腺苷脱氨酶(ADA)抑制剂的活性形成对比;(+)-EHNA作为ADA抑制剂的效力比(-)-EHNA高250倍[贝索德斯等人。生物化学与药物化学。31, 879 (1982)]。(+)-THNA的抗疱疹活性仅略低于EHNA异构体,而(-)-THNA的活性则稍低。EHNA和THNA的四种异构体抑制HSV感染细胞中DNA合成的能力与其抑制病毒增殖的能力相关。EHNA未能抑制感染细胞提取物中的HSV DNA聚合酶活性。此外,在感染后6小时向感染细胞中添加EHNA不会抑制DNA合成。这些结果与EHNA直接抑制大分子DNA合成不一致。用EHNA处理HSV感染细胞会使四种DNA前体脱氧核糖核苷5'-三磷酸(dNTPs)的水平降低2至4倍。这种处理对未感染细胞中dNTP水平的影响要小得多。